Loading...

75.00

One pre-filled syringe of 15.4mg/0.7ml

BUY RenehaVis

Loading...

BUY RenehaVis  is a sodium hyaluronate product, comprising a dual-chambered prefilled syringe that enables administration of both high and low molecular weight hyaluronate in a single intra-articular injection. Using high and low molecular weight sodium hyaluronate improves both cushioning and elasticity, enabling improvement in movement and pain relief at rest and during activity.

A product designed to relieve pain and stiffness of the knee joint in patients with degenerative changes to the synovial joint, including osteoarthritis. RenehaVis contains 2 different Hyaluronic Acids with 2 different concentrations in 1 syringe, either 15.4mg/0.7ml or 7.0mg/0.7ml.

BUY RenehaVis is a modern, innovative and unique two-chamber injection that administrate two forms of hyaluronic acid (HA) in a single injection. The first form of hyaluronic acid in RenehaVis is low molecular, which gives protection while strengthening the cartilage on the joint surface and supports the body’s own production of acid. The second form of hyaluronic acid in RenehaVis is high molecular, which ensures a mechanical effect in the affected joint. The combination of the two forms of hyaluronic acid reduces pain, while improving the elasticity and mobility of the damaged joint. RenehaVis can also be injected in the early phases of osteoarthritis.

Renehavis Injection

Renehavis pre-filled syringe
Renehavis is a one pre-filled syringe (two-chamber with 0.7ml of hyaluronic sodium LMW 22mg / ml and 0.7ml of hyaluronic sodium HMW 10mg / m) for a sequential injection. See details about, what is it for, composition of administration and its prospect at BCNPharma

What is Renehavis?
Renehavis what is it for?
How is the syringe
Renehavis is manufactured by laboratory:
Check the online prospectus:
Renehavis composition:

It is the only product in the world that contains two hyaluronic acids in a syringe for a sequential injection.
Renehavis what is it for?
RenehaVis® is a treatment performed by two injections (over a period of two weeks) for osteoarthritis of the knee.
It must be administered by a health professional since its application is intra-articular (inside the synovial capsule of the knee).
RenehaVis® is presented in a patented double-chamber syringe containing two hyaluronic acids of different molecular weight, which are administered sequentially.

The syringe
The first chamber contains Hyaluronic Acid of low molecular weight at high concentration.
The second chamber contains Hyaluronic Acid of high molecular weight at low concentration.
This product is protected by 3 patents:
Product design.
Syringe design.
Production of 2 Hyaluronic Acids.

Studies
Clinical studies have clearly shown that RenehaVis® manages to reduce pain at rest and in a situation of weight overload, more quickly than other hyaluronic acids of low and high molecular weight.
Renehavis is manufactured by laboratory:
Check the online prospectus:
Renehavis composition: Contains a two-chamber pre-filled syringe with 0.7ml of sodium hyaluronic acid LMW 22mg / ml and 0.7ml of hyaluronic sodium HMW 10mg / ml

Reviews

There are no reviews yet.

Be the first to review “BUY RenehaVis”

Your email address will not be published. Required fields are marked *

error: Content is protected !!